Synopsis of recent research by authors named "Alberto Ranghiero"
- Recent research by Alberto Ranghiero focuses on the integration of molecular and genomic analysis in oncology, particularly in understanding cancer progression, treatment resistance, and patient outcomes in various cancers such as laryngeal dysplasia, non-small-cell lung cancer, and breast cancer.
- His studies reveal significant insights into the roles of immune response, genomic alterations, and the effectiveness of new therapeutic strategies based on circulating tumor DNA (ctDNA) and homologous recombination deficiency (HRD) testing, contributing to personalized treatment approaches.
- Ranghiero’s work emphasizes the importance of geographical accessibility and molecular matching in clinical trials, indicating a need for improved patient access to cutting-edge treatments and the potential of a molecular tumor board to enhance precision oncology efforts.
